Emergent BioSolutions Inc (FRA:ER4)
€ 6.54 +0.14 (+2.19%) Market Cap: 337.36 Mil Enterprise Value: 695.76 Mil PE Ratio: 0 PB Ratio: 0.75 GF Score: 61/100

Q2 2025 Emergent BioSolutions Inc Earnings Call Transcript

Aug 6, 2025 / 09:00 PM GMT
Release Date Price: €5.24 (+2.22%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EBS.N - Emergent BioSolutions Inc
Q2 2025 Emergent BioSolutions Inc Earnings Call
Aug 06, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everyone.

Thank you for joining today as Emergent discusses their operational and financial results for the 2nd quarter of 2025.

As is customary, today's call is open to all participants. The call is being recorded and is copyrighted by emergent biosoluts.

In addition to today's press release, there are a series of slides accompanying this webcast available to all webcast participants.

Turning to slide 2.

During today's call, a merchant may make projections and other forward-looking statements related to their business, future events, their prospects, or future performance.

These forward-looking statements are based on their current intentions, beliefs,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot